[go: up one dir, main page]

CN103896975B - A kind of synthetic method of 3-cyclic ethers methyl trifluoro potassium borate - Google Patents

A kind of synthetic method of 3-cyclic ethers methyl trifluoro potassium borate Download PDF

Info

Publication number
CN103896975B
CN103896975B CN201410106143.0A CN201410106143A CN103896975B CN 103896975 B CN103896975 B CN 103896975B CN 201410106143 A CN201410106143 A CN 201410106143A CN 103896975 B CN103896975 B CN 103896975B
Authority
CN
China
Prior art keywords
cyclic ethers
methyl
tetramethyl ethylene
potassium borate
ethylene ketone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201410106143.0A
Other languages
Chinese (zh)
Other versions
CN103896975A (en
Inventor
侯海荣
曹丹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SUNDIA MEDITECH (SHANGHAI) Co Ltd
Original Assignee
SUNDIA MEDITECH (SHANGHAI) Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SUNDIA MEDITECH (SHANGHAI) Co Ltd filed Critical SUNDIA MEDITECH (SHANGHAI) Co Ltd
Priority to CN201410106143.0A priority Critical patent/CN103896975B/en
Publication of CN103896975A publication Critical patent/CN103896975A/en
Application granted granted Critical
Publication of CN103896975B publication Critical patent/CN103896975B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The present invention relates to 3-cyclic ethers methyl trifluoro potassium borate, particularly relate to the synthetic method of 3-cyclic ethers methyl trifluoro potassium borate, mainly solve expensive catalyst that existing preparation method exists, the technical problem such as reaction conditions is violent, synthetic route is long.Technical solution of the present invention: a kind of synthetic method of synthesizing 3-cyclic ethers methyl trifluoro potassium borate: with 2-cyclic ethers alkene for after raw material and borine addition, tetramethyl ethylene ketone cancellation obtains 3-cyclic ethers base tetramethyl ethylene ketone boric acid ester; Then highly basic deprotonation, is obtained by reacting 3-cyclic ethers methyl tetramethyl ethylene ketone boric acid ester with methyl chlorobromide; Last and potassium hydrogen fluoride is obtained by reacting 3-cyclic ethers methyl trifluoro potassium borate.This compounds is important medical compounds structural modification small molecules in new drug research field.

Description

A kind of synthetic method of 3-cyclic ethers methyl trifluoro potassium borate
Technical field
The present invention relates to 3-cyclic ethers methyl trifluoro potassium borate, particularly relate to the synthetic method of 3-cyclic ethers methyl trifluoro potassium borate, this compounds is important medical compounds structural modification small molecules in new drug research field.
Background technology
Boric acid compound and derivative thereof are a class in organic synthesis field by the compound of extensive concern, and it has, and stable in properties, reactive behavior are high, the feature of environmental protection.This compounds is used for the intermediate of transition-metal catalysis usually used as electrophilic center, thus builds C-C key, and compare the linked reaction of grignard reagent, zincon, lithium reagent participation, this kind of reaction has better functional group tolerance.In recent years along with the catalyzer for boric acid ester compound and multiple halohydrocarbon coupled reaction is developed in succession, the application of this compounds in C-C key, C-O key, C-N key, the formation of C-S key is also more and more extensive.In biological medicine research field, organoboron compound has more application in synthesis cancer therapy drug, antitumor drug, anti-deterioration medicine etc.3-cyclic ethers methyl trifluoro potassium borate is a wherein compounds structural modification small molecules, and be widely used in medicament research and development and synthesis aspect, as compound 1, compound 2, compound 3 and compound 4 are the molecule of pharmaceutical activity.
US2012/0226041A1 discloses a kind of synthetic method of synthesizing cyclic ethers base tetramethyl ethylene ketone boric acid ester, take cyclic ethers as raw material, (η 6-sym-trimethylbenzene) iridium three (tetramethyl ethylene ketone borine) is catalyzer, 3,4,7,8-tetramethyl--1,10-phenanthrolines are part, react with duplex tetramethyl ethylene ketone borine, prepare cyclic ethers base tetramethyl ethylene ketone boric acid ester (formula 1).
Formula 1:
The synthetic method of 3-cyclic ethers methyl trifluoro potassium borate has no report, and the synthetic method of similar cycloalkanes methyl-boron-dihydroxide ester has three kinds, for hexanaphthene: 1. " German applied chemistry " discloses methylcyclohexane and duplex tetramethyl ethylene ketone borine at catalyzer: cyclopentadiene three rhenium carbonyl [C 5h 5re (CO) 3] catalysis under prepare (formula 2, Angew.Chem.Int.Ed. 1999,38 (22), 3391);
Formula 2:
2. after " German applied chemistry " discloses hexahydrobenzaldehyde and tosic acid hydrazine reaction, be obtained by reacting with tetramethyl ethylene ketone borine in the basic conditions (formula 3, Angew.Chem.Int.Ed. 2012,51 (12), 2943);
Formula 3:
3. methylenecyclohexane and 9-boron dicyclo (3,3,1)-nonane are obtained by reacting (formula 4, WO2007/67612A1):
Formula 4:
And for the synthesis of 3-cyclic ethers methyl tetramethyl ethylene ketone boric acid ester, if use similar approach, corresponding raw material is not easy to obtain, expensive or need multistep synthesize just can obtain, as tetrahydropyrans-3-formaldehyde sigma offers 25mg 86 dollars, 3-methyl tetrahydropyrans and 3-methylene radical tetrahydropyrans all need two steps to synthesize to obtain (formula 5); For needing the reaction of using catalyzer, not only can cause heavy metal contamination to environment, and production cost can be made to increase.
Formula 5:
Summary of the invention
The method of existing synthesis 3-cycloalkanes methyl trifluoro potassium borate compounds has many unfavorable factors, needs to use costliness and the catalyzer be not easy to obtain, as (η 6-sym-trimethylbenzene) iridium (tetramethyl ethylene ketone borine) 3with ring penta triolefin three carbon monoxide rhenium etc., and the use of precious metal can bring environmental pollution, and environment is unfriendly; Reaction conditions is violent, narrates reaction pressure 1520 Torr(2 normal atmosphere described in temperature of reaction 120 DEG C, formula two such as formula 1); And route is long, raw material is not easy to obtain, and such as formula the raw material that unconventional class in 3 and formula 4 can commercially buy, needs multistep to synthesize and obtains, add preparation cost.The invention provides a kind of method and can obtain 3-cyclic ethers methyl trifluoro potassium borate compounds efficiently, use the method technique is simple, yield is high, cost is low, raw material is easy to get, operate and purifying is convenient, purifying products is simple, be suitable for suitability for industrialized production, is also the synthesis supplying method reference of similar structures small molecules boric acid ester compound.
Technical solution of the present invention: a kind of synthetic method (formula 6) of synthesizing 3-cyclic ethers methyl trifluoro potassium borate: with 2-cyclic ethers alkene for after raw material and borine addition, tetramethyl ethylene ketone cancellation obtains 3-cyclic ethers base tetramethyl ethylene ketone boric acid ester; Then highly basic deprotonation, is obtained by reacting 3-cyclic ethers methyl tetramethyl ethylene ketone boric acid ester with methyl chlorobromide; Last and potassium hydrogen fluoride is obtained by reacting 3-cyclic ethers methyl trifluoro potassium borate.
Formula 6:
n=1,2。
Described 2-cyclic ethers alkene is the one in 2,3 dihydro furan or 3,4-dihydropyrane.
Described highly basic is n-Butyl Lithium.
Described 3-cyclic ethers methyl trifluoro potassium borate is the one in 3-tetrahydrofuran methyl three potassium fluoborate or 3-tetrahydropyrans methyl trifluoro potassium borate.
Advantageous Effects of the present invention: the raw material 2 used in the present invention, 3-dihydrofuran (280 yuan/500g) and 3,4-dihydro-2H-pyrans (180 yuan/500g) low price, to be easy to get, other reagent used also are conventional reagent, preparation cost is very cheap, avoids using highly toxic organotin reagent or and the rare heavy metal catalyst of costliness.By three steps, wherein only the first step needs to use simple column chromatography purification, and operation is conventional, and aftertreatment is simple, and product is easy to get, and avoids high-temperature high-voltage reaction condition or heavy metal catalyst, reaction can be handling and repeatability is all fine.
Embodiment
embodiment 1
1) 3-tetrahydrofuran base tetramethyl ethylene ketone boric acid ester
In a dry 1000mL there-necked flask, add 25 g 2,3 dihydro furans and 120 mL anhydrous tetrahydro furans, reaction solution is cooled to 0 DEG C, 360 mL 1M borine/tetrahydrofuran solutions are slowly added drop-wise in reaction solution.44 g tetramethyl ethylene ketones are dissolved in 100 mL tetrahydrofuran (THF)s, are slowly added drop-wise in reaction solution.Reaction solution stirred overnight at room temperature.Be added drop-wise to slowly in reaction solution by water, be extracted with ethyl acetate, flash column chromatography after organic phase is concentrated, obtains 3-tetrahydrofuran base tetramethyl ethylene ketone boric acid ester 29g, yield 41%. 1H-NMR (300 MHz, CDCl 3): δ3.93-3.96 (m, 1H), 3.75-3.81 (m, 1H), 3.56-3.71 (m, 2H), 1.97-2.02 (m, 1H), 1.76-1.87 (m, 1H), 1.54-1.60 (m, 1H), 1.25 (s, 12H)。
) 3-tetrahydrofuran methyl tetramethyl ethylene ketone boric acid ester
In a dry 500mL there-necked flask, add 29g 3-tetrahydrofuran base tetramethyl ethylene ketone boric acid ester and 250mL anhydrous tetrahydro furan, reaction solution is cooled to-78 DEG C.N-Butyl Lithium/the tetrahydrofuran solution of 58mL 2.5M is added drop-wise in reaction solution slowly, and then 20g methyl chlorobromide is added drop-wise in reaction solution slowly.Reaction solution is slowly warming up to room temperature, then stirred overnight at room temperature.Poured into by reaction solution in ammonium chloride saturated aqueous solution, be extracted with ethyl acetate, organic phase is dry, concentrated, obtains 3-tetrahydrofuran methyl tetramethyl ethylene ketone boric acid ester crude product 30g. 1H-NMR (300 MHz, CDCl 3): δ3.82-3.91 (m, 1H), 3.74-3.81 (m, 1H), 3.69-3.72 (m, 1H), 3.17-3.23 (m, 1H), 2.26-2.33 (m, 1H), 1.99-2.06 (m, 1H), 1.40-1.48 (m, 1H), 1.21 (s, 12H), 0.83-0.86 (d, 2H)。
) 3-tetrahydrofuran methyl three potassium fluoborate
In dry 2000 mL there-necked flasks, add 30g 3-tetrahydrofuran methyl tetramethyl ethylene ketone boric acid ester crude product and 600mL acetonitrile, 29 g potassium hydrogen fluorides are dissolved in 500mL water, are added dropwise to reaction solution, stirred overnight at room temperature.Concentrated except desolventizing, 500 mL methanol ethyl acetate mixed solvents (methyl alcohol: ethyl acetate=2ml:1ml) are added in condensate residue, stirs 30 minutes.Filter, filtrate is concentrated.200mL methyl tertiary butyl ether is added in condensate residue, stirs 30 minutes.Filter, solid vacuum-drying.Obtain 3-tetrahydrofuran methyl three potassium fluoborate 26g, yield 92%. 1H-NMR (300 MHz, D 2O): δ3.69-3.80 (m, 2H), 3.57-3.62 (m, 1H), 3.06-3.12 (t, 1H), 1.91-2.05 (m, 2H), 1.33-1.40 (m, 1H), 0.19-0.24 (m, 2H)。
Embodiment 2:
1) 3-THP trtrahydropyranyl tetramethyl ethylene ketone boric acid ester
In a dry 1000mL there-necked flask, add 25 g 3,4-dihydropyrane and 120 mL anhydrous tetrahydro furans, reaction solution is cooled to 0 DEG C, 300 mL 1M borine/tetrahydrofuran solutions are slowly added drop-wise in reaction solution.35 g tetramethyl ethylene ketones are dissolved in 100 mL tetrahydrofuran (THF)s, are slowly added drop-wise in reaction solution.Reaction solution stirred overnight at room temperature.Be added drop-wise to slowly in reaction solution by water, be extracted with ethyl acetate, flash column chromatography after organic phase is concentrated, obtains 3-THP trtrahydropyranyl tetramethyl ethylene ketone boric acid ester 28g, yield 45%. 1H-NMR (300 MHz, CDCl 3): δ3.78-3.89 (m, 2H), 3.40-3.51 (m, 2H), 1.79-1.82 (m, 1H), 1.48-1.57 (m, 3H), 1.29-1.32 (m, 1H), 1.23 (s, 12H)。
) 3-tetrahydropyrans methyl tetramethyl ethylene ketone boric acid ester
Prepare N-Lithiodiisopropylamide (LDA): in a dry 500mL there-necked flask 1, add 150mL tetrahydrofuran (THF) and 14g Diisopropylamine.Reaction solution is cooled to-60 DEG C, and the n-Butyl Lithium/hexane solution of 53mL 2.5M is slowly added drop-wise in reaction solution.Reaction solution is slowly warmed up to 0 DEG C, stirs 30 minutes.
In a dry 1000mL there-necked flask, add 28g 3-THP trtrahydropyranyl tetramethyl ethylene ketone boric acid ester and 250mL anhydrous tetrahydro furan, reaction solution is cooled to-78 DEG C.Be added drop-wise to slowly in reaction solution by the LDA/THF solution prepared, then 17 g methyl chlorobromides are added drop-wise in reaction solution slowly.Reaction solution is slowly warming up to room temperature, then stirred overnight at room temperature.Poured into by reaction solution in ammonium chloride saturated aqueous solution, be extracted with ethyl acetate, organic phase is dry, concentrated, obtains 3-tetrahydropyrans methyl tetramethyl ethylene ketone boric acid ester crude product 32g. 1H-NMR (300MHz, CDCl 3): δ3.78-3.86 (m, 2H), 3.23-3.30 (m, 1H), 2.91-1.2.96 (m, 1H), 1.74-1.85 (m, 1H), 1.47-1.62 (m, 3H), 1.25-1.30 (m, 1H), 1.23 (s, 12H), 0.59-0.61 (d, 2H)。
) 3-tetrahydropyrans methyl trifluoro potassium borate
In dry 2000 mL there-necked flasks, add 32g 3-tetrahydropyrans methyl tetramethyl ethylene ketone boric acid ester crude product and 600mL acetonitrile, 26g potassium hydrogen fluoride is dissolved in 500mL water, is added dropwise to reaction solution, stirred overnight at room temperature.Concentrated except desolventizing, 500 mL methanol ethyl acetate mixed solvents (methyl alcohol: ethyl acetate=2ml:1ml) are added in condensate residue, stirs 30 minutes.Filter, filtrate is concentrated.200mL methyl tertiary butyl ether is added in condensate residue, stirs 30 minutes.Filter, solid vacuum-drying.Obtain 3-tetrahydropyrans methyl trifluoro potassium borate 27.5g, yield 95%. 1H-NMR (300MHz, D 2O): δ3.67-3.70 (d, 2H), 3.08-3.16 (m, 1H), 2.70-2.77 (t, 1H), 1.72-1.77 (d, 1H), 1.34-1.42 (m, 3H), 0.83-0.97 (m, 1H), 0.26-0.17 (m, 2H)。
Embodiment 3:
1) 2-(4-chloro-phenyl-)-4-(3-tetrahydrofuran methyl) thieno-[2,3-d] pyrazine-7-methane amide
In dry 250 mL there-necked flasks; the chloro-2-of 4-(4-c chloro-phenyl-)-thieno-[2 is added under nitrogen protection; 3-d] pyrazine-7-methane amide (10.0g); anhydrous tetrahydro furan (100 mL) and 1; two (diphenylphosphino) ferrocene of 1'-] palladium chloride (1.13g); then add 3-tetrahydrofuran methyl three potassium fluoborate (6.53g), reaction mixture spends the night 60 DEG C of stirrings.After cool to room temperature, add saturated aqueous ammonium chloride, layering, aqueous layer with ethyl acetate extracts.After merging organic layer, saturated common salt is washed, anhydrous sodium sulfate drying, concentrates except desolventizing obtains crude product.Crude product column layer chromatography silicone rubber purifying (petrol ether/ethyl acetate volume ratio=5/1) obtains 2-(4-chloro-phenyl-)-4-(3-tetrahydrofuran methyl) thieno-[2, the 3-d] pyrazine-7-methane amide of 7.04g, yield 61%. 1h-NMR (300MHz, DMSO-d6): δ 7.55-7.45 (d, 2H), 7.38-7.30 (d, 2H), 7.02 (s, 1H), 6.52 (s, 2H), 3.85-3.58 (m, 2H), 3.57-3.62 (m, 1H), 3.06-3.12 (t, 1H), 1.91-2.05 (m, 2H), 1.33-1.40 (m, 1H), 0.19-0.24 (m, 2H).

Claims (2)

1. a synthetic method for 3-cyclic ethers methyl trifluoro potassium borate, is characterized in that: reaction comprises the following steps:
1) with 2-cyclic ethers alkene for raw material, after reacting with borine, obtain 3-cyclic ethers base tetramethyl ethylene ketone boric acid ester with tetramethyl ethylene ketone cancellation,
Wherein n=1,2;
2), after 3-cyclic ethers base tetramethyl ethylene ketone boric acid ester and highly basic deprotonation, react with methyl chlorobromide, obtain 3-cyclic ethers methyl tetramethyl ethylene ketone boric acid ester,
Wherein n=1,2;
3) 3-cyclic ethers methyl tetramethyl ethylene ketone boric acid ester and potassium hydrogen fluoride obtain 3-cyclic ethers methyl trifluoro potassium borate after reacting,
Wherein n=1,2.
2. the synthetic method of a kind of 3-cyclic ethers methyl trifluoro potassium borate according to claim 1, is characterized in that: the highly basic that described deprotonation uses is n-Butyl Lithium.
CN201410106143.0A 2014-03-21 2014-03-21 A kind of synthetic method of 3-cyclic ethers methyl trifluoro potassium borate Active CN103896975B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410106143.0A CN103896975B (en) 2014-03-21 2014-03-21 A kind of synthetic method of 3-cyclic ethers methyl trifluoro potassium borate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410106143.0A CN103896975B (en) 2014-03-21 2014-03-21 A kind of synthetic method of 3-cyclic ethers methyl trifluoro potassium borate

Publications (2)

Publication Number Publication Date
CN103896975A CN103896975A (en) 2014-07-02
CN103896975B true CN103896975B (en) 2015-08-26

Family

ID=50988590

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410106143.0A Active CN103896975B (en) 2014-03-21 2014-03-21 A kind of synthetic method of 3-cyclic ethers methyl trifluoro potassium borate

Country Status (1)

Country Link
CN (1) CN103896975B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104478910A (en) * 2014-12-17 2015-04-01 成都安斯利生物医药有限公司 Preparation method of potassium (cis)-2-substituted-2-bromo-olefin trifluoroborate
CN104672261A (en) * 2015-02-27 2015-06-03 成都安斯利生物医药有限公司 Method for preparing tetrahydrofuran-3-boric acid pinacol ester
CN104592278A (en) * 2015-02-28 2015-05-06 成都安斯利生物医药有限公司 Method for preparing tetrahydropyrane-3-boronic acid pinacol ester

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102060867A (en) * 2010-12-31 2011-05-18 大连联化医药技术有限公司 Method for preparing potassium trifluoroborate series compounds
CN102786541A (en) * 2012-07-24 2012-11-21 上海瑞博化学有限公司 Preparation method and application of potassium (iso)quinoline thifluoroborate
CN103044472A (en) * 2012-12-20 2013-04-17 大连联化化学有限公司 Method for preparing vinyl potassium trifluoborate
CN103421032A (en) * 2012-05-17 2013-12-04 上海希迈医药科技有限公司 Bortezomib intermediate, and preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120226041A1 (en) * 2011-03-04 2012-09-06 The Board Of Trustees Of The University Of Illinois Catalysts and boronate esters

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102060867A (en) * 2010-12-31 2011-05-18 大连联化医药技术有限公司 Method for preparing potassium trifluoroborate series compounds
CN103421032A (en) * 2012-05-17 2013-12-04 上海希迈医药科技有限公司 Bortezomib intermediate, and preparation method and application thereof
CN102786541A (en) * 2012-07-24 2012-11-21 上海瑞博化学有限公司 Preparation method and application of potassium (iso)quinoline thifluoroborate
CN103044472A (en) * 2012-12-20 2013-04-17 大连联化化学有限公司 Method for preparing vinyl potassium trifluoborate

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Combining high pressure and catalysis: pinacol- or catecholborane hydroboration of functionalized olefins;Sylvie Colin 等;《J. Chem. Soc., Perkin Trans. 1》;20001107;第4505–4511页 *
Potassium Organotrifluoroborates:New Perspectives in Organic Synthesis;Sylvain Darses 等;《Chem.Rev》;20071221;第108卷(第1期);第288-325页 *
rganotrifluoroborates:Protected Boronic Acids That Expand the Versatility of the Suzuki Coupling Reaction;GARY A.MOLANDER 等;《Acc.Chem.Res》;20070126;第40卷(第4期);第275-286页 *

Also Published As

Publication number Publication date
CN103896975A (en) 2014-07-02

Similar Documents

Publication Publication Date Title
Karimi-Jaberi et al. Tris (hydrogensulfato) boron as a solid heterogeneous catalyst for the rapid synthesis of α, α′-benzylidene bis (4-hydroxycoumarin) derivatives
Pawlowski et al. Radical‐Mediated Non‐Dearomative Strategies in Construction of Spiro Compounds
CN103896975B (en) A kind of synthetic method of 3-cyclic ethers methyl trifluoro potassium borate
CN102952156A (en) Anti-hepatitis B drug entecavir intermediate and synthesis thereof
JP6487568B2 (en) Kinetic resolution by catalytic asymmetric hydrogenation of racemic δ-hydroxy ester and its application
Li et al. Visible-light-induced photocatalyst-free activation of alkynyl triflones for trifluoromethylalkynylation of unactivated 1, 6-dialkenes
CN104250236A (en) Synthetic method of gamma-alkyl oxyacyl methyl-gamma-butyrolactone and delta- alkyl oxyacyl methyl-delta-valerolactone
CN103159776B (en) The total synthesis method of a kind of natural active product hypoxylonin and analogue thereof
Tiefenbacher et al. An expeditious asymmetric formal synthesis of the antibiotic platensimycin
CN102304062B (en) Method for preparing Salen Ni
Das et al. Stereoselective direct reductive amination of ketones with electron-deficient amines using Re 2 O 7/NaPF 6 catalyst
CN105399718A (en) Solid phase synthesis method of 2H-benzopyran compounds
CN107056829B (en) BODIPY derivative containing uracil group and preparation method thereof
CN109232350A (en) A method of preparing N-Boc-3- pyrrolidine formaldehyde
CN108047032A (en) By α-ketoglutaric acid to glutaric acid synthetic method
CN107216332A (en) The synthetic method of (6H) the formic acid base ester of 7 methylol of the tert-butyl group, 7,8 dihydro 4H pyrazolos diazepine 5
CN109422654A (en) The method of synthetic fatty amine methylated compounds
Wu et al. Enantioselective synthesis of 1-aminoindene derivatives via asymmetric Brønsted acid catalysis
CN108178741B (en) β-alkynes seleno alcohols organic compound synthetic method
CN106496080A (en) A kind of preparation method of mercapto-functionalized aryl carboxylic acid
Li et al. Manganese-Promoted Cyclization Reaction of Enynones with Tetrasulfides: Synthesis of Multisubstituted Furanmethyl Disulfides
CN103936753B (en) Natural products Daldinin and the like total synthesis method
CN108976182A (en) A method of preparing Dapagliflozin five-membered ring impurity
CN113461677B (en) Preparation method of 4-hydroxy-2-methyl-3- (thiophene-2-sulfonyl) thiazolidine-2-carboxylic acid methyl ester
CN101891716A (en) A kind of synthetic method of S-β-hydroxyl-γ-butyrolactone

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant